Comments

AbCellera Biologics Stock News

ABCLNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$2.68
0.093.67%
Q4 2024 Earnings were released on Thu Feb 27th, after the market close
The most recent conference call was at 17:00 PM, 4 days ago Click to view past webcast
AbCellera Biologics (ABCL) Forecast

News

EarningsAbCellera Biologics (ABCL) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Latest AbCellera Biologics Stock News | NASDAQ:ABCL | Benzinga

Get the latest news on AbCellera Biologics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on AbCellera Biologics performance

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved